Jamie Hogan, OD,

A Review of the Management of Fuchs Endothelial Corneal Dystrophy

Fuchs Endothelial Corneal Dystrophy leads to progressive visual deterioration that may cause acutely painful episodes. Medical management  has been limited to prescribing hyperosmotic agents. The advancement in therapeutic and surgical management has led to earlier intervention, better visual prognosis, and improved quality of life for patients affected by FECD. Optometrists play a role in the management of this condition’s diagnosis, treatment, and postsurgical care.

Read More

In Partnership With

Subscribe


Our Authors

1 post(s)
General Practitioner from Mérida, Yucatán, and a proud graduate of UPAEP.
14 post(s)
Dr. Rett is the Editor-in-Chief of the Journal of Medical Optometry and the secretary for the American Board of Certification…
4 post(s)
Dr. Leslie Wilderson, OD, FAAO, Dipl AAO earned both her Bachelor of Science in Vision Science and Doctor of Optometry…
1 post(s)
Dr. Emily Coan graduated from the Southern California College of Optometry in 2025 and completed a residency in Ocular Disease…
5 post(s)
Dr. Canellos is a full-time faculty member of SUNY State College of Optometry. She is an Associate Clinical Professor, Instructor…
2 post(s)
Dr. Muscente is an optometrist practicing at Richmond University Medical Center and Level 1 Trauma Center. He is a graduate…
13 post(s)
Dr. Kane graduated from New England College of Optometry in 2015 and went on to complete an ocular disease/primary care…
1 post(s)
Dr. Glass earned her optometry degree from the University of Houston College of Optometry. Her training included rotations in ocular…
1 post(s)
Len Koh is a staff optometrist and residency site director at the Mann-Grandstaff VA Medical Center in Spokane, Washington. He…
1 post(s)
Dr. Wang graduated from the New England College of Optometry in 2025. She completed her ocular disease residency at the…